Advertisement

Supply Chain


Atorvastatin calcium makes up 2.8 percent of outpatient prescription medication claims, according to a Dec. 30 report from Definitive Healthcare. 

Valencia, Calif.-based Advanced Biologics has agreed to pay over $12 million for allegedly violating the False Claims Act by misleading federal programs regarding radio-frequency emissions generated by cochlear implants, according to a Dec. 20 report from the Justice Department.

Case numbers have long recovered since the onset of the COVID-19 pandemic, but ASC leaders are still struggling with supply costs as they compete for contracts with the deep pockets of hospitals and health systems. 

The ambulatory surgery center (ASC) industry is growing exponentially due to improved surgical capabilities and changing reimbursement incentives. As ASCs grow, the ASC supply chain is growing in complexity. This makes supply chain data essential in making sound decisions.

Advertisement
Advertisement
Advertisement